Corrigendum to “The epidemiology and burden of neuromyelitis optica spectrum disorder, multiple sclerosis, and MOG antibody-associated disease in a province in Thailand: A population-based study” [Multiple Sclerosis and Related Disorders, Volume 70, February 2023, 104511] (Multiple Sclerosis and Related Disorders (2023) 70, (S2211034823000159), (10.1016/j.msard.2023.104511))
Tisavipat N., Jitpratoom P., Siritho S.A., Prayoonwiwat N.A., Apiwattanakul M.e., Boonyasiri A.f., Rattanathamsakul N., Jitprapaikulsan J.A. Corrigendum to “The epidemiology and burden of neuromyelitis optica spectrum disorder, multiple sclerosis, and MOG antibody-associated disease in a province in Thailand: A population-based study” [Multiple Sclerosis and Related Disorders, Volume 70, February 2023, 104511] (Multiple Sclerosis and Related Disorders (2023) 70, (S2211034823000159), (10.1016/j.msard.2023.104511)). Multiple Sclerosis and Related Disorders (2026). doi:10.1016/j.msard.2026.107240 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/116841
Title
Corrigendum to “The epidemiology and burden of neuromyelitis optica spectrum disorder, multiple sclerosis, and MOG antibody-associated disease in a province in Thailand: A population-based study” [Multiple Sclerosis and Related Disorders, Volume 70, February 2023, 104511] (Multiple Sclerosis and Related Disorders (2023) 70, (S2211034823000159), (10.1016/j.msard.2023.104511))
The authors regret that the grant number was listed incorrectly. The correct number is- This study was approved by the Siriraj Institutional Review Board (COA no. Si 619/2011) and CPH. The authors would like to apologise for any inconvenience caused.
